MYC and small cell lung carcinoma: Additionally, high MYC activity correlates with SCLC transformation in multiple experimental models [53,57], and MYC over-expression is a key component of the oncogenic cocktail that drives NE conversion in the ACB/PARCB xenograft model [50,51], further implicating MYC in SCLC transformation.